Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio Farhat Nasim14 Oct 2019 1:36 PM ISTWhile two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
Morepen Labs Q1 export sale of Atorvastatin Calcium up by 57 percent Medical Dialogues Bureau17 Aug 2019 9:13 AM ISTMorepen Labs' export sales in Q1'FY 2019-20 for Montelukast Sodium rose by 210 per cent and that of Atorvastatin Calcium by 57 per cent vis-a-vis the...
Morepen labs gets USFDA approval for 2 bulk drug manufacturing units Ruby Khatun Khatun1 Aug 2018 10:47 AM ISTNew Delhi: Morepen Laboratories Ltd. has received USFDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing...
Morepen Labs gets USFDA nod for asthma drug Ruby Khatun Khatun21 Dec 2017 2:09 PM ISTNew Delhi: Morepen Laboratories said the US health regulator has given approval to Montelukast Sodium, used in managing asthma symptoms and seasonal...
Morepen Labs reports 24 percent jump in its Q2 net profit Ruby Khatun Khatun14 Nov 2017 10:16 AM ISTNew Delhi: Morepen Laboratories Ltd. has reported a stable set of numbers in the second quarter (Q2) of fiscal 2017-18. The company has registered a...
Morepen Labs ties up with Vesale Pharma of Belgium Ruby Khatun Khatun11 Nov 2017 10:32 AM ISTNew Delhi: Morepen Laboratories Ltd. entered into a tie-up with Vesale Pharma International of Belgium to strengthen its position in the Rs. 1000...
